Financhill
Sell
23

VERO Quote, Financials, Valuation and Earnings

Last price:
$0.40
Seasonality move :
-41%
Day range:
$0.39 - $0.45
52-week range:
$0.26 - $14.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
0.26x
Volume:
29.4K
Avg. volume:
1M
1-year change:
-87.66%
Market cap:
$706.5K
Revenue:
$64.8M
EPS (TTM):
-$48.84

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
VERO
Venus Concept, Inc.
$14.5M -$0.92 -3.5% -54.23% --
AORT
Artivion, Inc.
$116.4M $0.18 16.97% -75% $51.43
CEOS
CeCors, Inc.
-- -- -- -- --
EW
Edwards Lifesciences Corp.
$1.5B $0.62 13.01% 16.86% $96.46
HRAL
Hear AtLast Holdings, Inc.
-- -- -- -- --
NTRB
Nutriband, Inc.
$765K -$0.17 4.52% -54.85% $15.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
VERO
Venus Concept, Inc.
$0.38 -- $706.5K -- $0.00 0% 0.01x
AORT
Artivion, Inc.
$38.62 $51.43 $1.8B 193.29x $0.00 0% 4.07x
CEOS
CeCors, Inc.
$0.0030 -- $999.2K -- $0.00 0% 0.42x
EW
Edwards Lifesciences Corp.
$85.28 $96.46 $49.5B 47.21x $0.00 0% 8.23x
HRAL
Hear AtLast Holdings, Inc.
$0.0004 -- $203.5K -- $0.00 0% --
NTRB
Nutriband, Inc.
$4.14 $15.00 $50.3M -- $0.00 0% 20.66x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
VERO
Venus Concept, Inc.
92.44% 3.162 689.6% 0.48x
AORT
Artivion, Inc.
36.58% 1.968 11.85% 1.52x
CEOS
CeCors, Inc.
-- -4.302 -- --
EW
Edwards Lifesciences Corp.
6.39% -0.166 1.43% 2.70x
HRAL
Hear AtLast Holdings, Inc.
-774.23% 0.828 -- 0.00x
NTRB
Nutriband, Inc.
3.31% 2.020 0.32% 7.07x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
VERO
Venus Concept, Inc.
$8.8M -$9.5M -129.08% -1236.95% -68.93% -$4.9M
AORT
Artivion, Inc.
$69.7M $12.5M 1.44% 2.6% 10.76% -$6.2M
CEOS
CeCors, Inc.
-- -- -- -- -- --
EW
Edwards Lifesciences Corp.
$1.2B $377.5M 9.62% 10.27% 24.05% $353.5M
HRAL
Hear AtLast Holdings, Inc.
-- -$51K -- -- -- -$21.3K
NTRB
Nutriband, Inc.
$63K -$3.9M -159.71% -164.64% -1121.15% -$1.8M

Venus Concept, Inc. vs. Competitors

  • Which has Higher Returns VERO or AORT?

    Artivion, Inc. has a net margin of -163.68% compared to Venus Concept, Inc.'s net margin of 2.09%. Venus Concept, Inc.'s return on equity of -1236.95% beat Artivion, Inc.'s return on equity of 2.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    VERO
    Venus Concept, Inc.
    64% -$12.14 $35.8M
    AORT
    Artivion, Inc.
    60.06% $0.05 $706.7M
  • What do Analysts Say About VERO or AORT?

    Venus Concept, Inc. has a consensus price target of --, signalling upside risk potential of 30584.21%. On the other hand Artivion, Inc. has an analysts' consensus of $51.43 which suggests that it could grow by 33.17%. Given that Venus Concept, Inc. has higher upside potential than Artivion, Inc., analysts believe Venus Concept, Inc. is more attractive than Artivion, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    VERO
    Venus Concept, Inc.
    0 1 0
    AORT
    Artivion, Inc.
    4 1 0
  • Is VERO or AORT More Risky?

    Venus Concept, Inc. has a beta of 0.051, which suggesting that the stock is 94.885% less volatile than S&P 500. In comparison Artivion, Inc. has a beta of 1.596, suggesting its more volatile than the S&P 500 by 59.647%.

  • Which is a Better Dividend Stock VERO or AORT?

    Venus Concept, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Artivion, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Venus Concept, Inc. pays -- of its earnings as a dividend. Artivion, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios VERO or AORT?

    Venus Concept, Inc. quarterly revenues are $13.8M, which are smaller than Artivion, Inc. quarterly revenues of $116M. Venus Concept, Inc.'s net income of -$22.5M is lower than Artivion, Inc.'s net income of $2.4M. Notably, Venus Concept, Inc.'s price-to-earnings ratio is -- while Artivion, Inc.'s PE ratio is 193.29x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Venus Concept, Inc. is 0.01x versus 4.07x for Artivion, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    VERO
    Venus Concept, Inc.
    0.01x -- $13.8M -$22.5M
    AORT
    Artivion, Inc.
    4.07x 193.29x $116M $2.4M
  • Which has Higher Returns VERO or CEOS?

    CeCors, Inc. has a net margin of -163.68% compared to Venus Concept, Inc.'s net margin of --. Venus Concept, Inc.'s return on equity of -1236.95% beat CeCors, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    VERO
    Venus Concept, Inc.
    64% -$12.14 $35.8M
    CEOS
    CeCors, Inc.
    -- -- --
  • What do Analysts Say About VERO or CEOS?

    Venus Concept, Inc. has a consensus price target of --, signalling upside risk potential of 30584.21%. On the other hand CeCors, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Venus Concept, Inc. has higher upside potential than CeCors, Inc., analysts believe Venus Concept, Inc. is more attractive than CeCors, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    VERO
    Venus Concept, Inc.
    0 1 0
    CEOS
    CeCors, Inc.
    0 0 0
  • Is VERO or CEOS More Risky?

    Venus Concept, Inc. has a beta of 0.051, which suggesting that the stock is 94.885% less volatile than S&P 500. In comparison CeCors, Inc. has a beta of 0.581, suggesting its less volatile than the S&P 500 by 41.886%.

  • Which is a Better Dividend Stock VERO or CEOS?

    Venus Concept, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CeCors, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Venus Concept, Inc. pays -- of its earnings as a dividend. CeCors, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios VERO or CEOS?

    Venus Concept, Inc. quarterly revenues are $13.8M, which are larger than CeCors, Inc. quarterly revenues of --. Venus Concept, Inc.'s net income of -$22.5M is higher than CeCors, Inc.'s net income of --. Notably, Venus Concept, Inc.'s price-to-earnings ratio is -- while CeCors, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Venus Concept, Inc. is 0.01x versus 0.42x for CeCors, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    VERO
    Venus Concept, Inc.
    0.01x -- $13.8M -$22.5M
    CEOS
    CeCors, Inc.
    0.42x -- -- --
  • Which has Higher Returns VERO or EW?

    Edwards Lifesciences Corp. has a net margin of -163.68% compared to Venus Concept, Inc.'s net margin of 4.09%. Venus Concept, Inc.'s return on equity of -1236.95% beat Edwards Lifesciences Corp.'s return on equity of 10.27%.

    Company Gross Margin Earnings Per Share Invested Capital
    VERO
    Venus Concept, Inc.
    64% -$12.14 $35.8M
    EW
    Edwards Lifesciences Corp.
    78.61% $0.11 $11B
  • What do Analysts Say About VERO or EW?

    Venus Concept, Inc. has a consensus price target of --, signalling upside risk potential of 30584.21%. On the other hand Edwards Lifesciences Corp. has an analysts' consensus of $96.46 which suggests that it could grow by 13.12%. Given that Venus Concept, Inc. has higher upside potential than Edwards Lifesciences Corp., analysts believe Venus Concept, Inc. is more attractive than Edwards Lifesciences Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    VERO
    Venus Concept, Inc.
    0 1 0
    EW
    Edwards Lifesciences Corp.
    16 12 0
  • Is VERO or EW More Risky?

    Venus Concept, Inc. has a beta of 0.051, which suggesting that the stock is 94.885% less volatile than S&P 500. In comparison Edwards Lifesciences Corp. has a beta of 0.927, suggesting its less volatile than the S&P 500 by 7.349%.

  • Which is a Better Dividend Stock VERO or EW?

    Venus Concept, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Edwards Lifesciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Venus Concept, Inc. pays -- of its earnings as a dividend. Edwards Lifesciences Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios VERO or EW?

    Venus Concept, Inc. quarterly revenues are $13.8M, which are smaller than Edwards Lifesciences Corp. quarterly revenues of $1.6B. Venus Concept, Inc.'s net income of -$22.5M is lower than Edwards Lifesciences Corp.'s net income of $64.2M. Notably, Venus Concept, Inc.'s price-to-earnings ratio is -- while Edwards Lifesciences Corp.'s PE ratio is 47.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Venus Concept, Inc. is 0.01x versus 8.23x for Edwards Lifesciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    VERO
    Venus Concept, Inc.
    0.01x -- $13.8M -$22.5M
    EW
    Edwards Lifesciences Corp.
    8.23x 47.21x $1.6B $64.2M
  • Which has Higher Returns VERO or HRAL?

    Hear AtLast Holdings, Inc. has a net margin of -163.68% compared to Venus Concept, Inc.'s net margin of --. Venus Concept, Inc.'s return on equity of -1236.95% beat Hear AtLast Holdings, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    VERO
    Venus Concept, Inc.
    64% -$12.14 $35.8M
    HRAL
    Hear AtLast Holdings, Inc.
    -- -- -$362.8K
  • What do Analysts Say About VERO or HRAL?

    Venus Concept, Inc. has a consensus price target of --, signalling upside risk potential of 30584.21%. On the other hand Hear AtLast Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Venus Concept, Inc. has higher upside potential than Hear AtLast Holdings, Inc., analysts believe Venus Concept, Inc. is more attractive than Hear AtLast Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    VERO
    Venus Concept, Inc.
    0 1 0
    HRAL
    Hear AtLast Holdings, Inc.
    0 0 0
  • Is VERO or HRAL More Risky?

    Venus Concept, Inc. has a beta of 0.051, which suggesting that the stock is 94.885% less volatile than S&P 500. In comparison Hear AtLast Holdings, Inc. has a beta of 0.307, suggesting its less volatile than the S&P 500 by 69.314%.

  • Which is a Better Dividend Stock VERO or HRAL?

    Venus Concept, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hear AtLast Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Venus Concept, Inc. pays -- of its earnings as a dividend. Hear AtLast Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios VERO or HRAL?

    Venus Concept, Inc. quarterly revenues are $13.8M, which are larger than Hear AtLast Holdings, Inc. quarterly revenues of --. Venus Concept, Inc.'s net income of -$22.5M is lower than Hear AtLast Holdings, Inc.'s net income of -$152.6K. Notably, Venus Concept, Inc.'s price-to-earnings ratio is -- while Hear AtLast Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Venus Concept, Inc. is 0.01x versus -- for Hear AtLast Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    VERO
    Venus Concept, Inc.
    0.01x -- $13.8M -$22.5M
    HRAL
    Hear AtLast Holdings, Inc.
    -- -- -- -$152.6K
  • Which has Higher Returns VERO or NTRB?

    Nutriband, Inc. has a net margin of -163.68% compared to Venus Concept, Inc.'s net margin of -1118.87%. Venus Concept, Inc.'s return on equity of -1236.95% beat Nutriband, Inc.'s return on equity of -164.64%.

    Company Gross Margin Earnings Per Share Invested Capital
    VERO
    Venus Concept, Inc.
    64% -$12.14 $35.8M
    NTRB
    Nutriband, Inc.
    18.2% -$0.32 $7.8M
  • What do Analysts Say About VERO or NTRB?

    Venus Concept, Inc. has a consensus price target of --, signalling upside risk potential of 30584.21%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 262.32%. Given that Venus Concept, Inc. has higher upside potential than Nutriband, Inc., analysts believe Venus Concept, Inc. is more attractive than Nutriband, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    VERO
    Venus Concept, Inc.
    0 1 0
    NTRB
    Nutriband, Inc.
    1 0 0
  • Is VERO or NTRB More Risky?

    Venus Concept, Inc. has a beta of 0.051, which suggesting that the stock is 94.885% less volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.801, suggesting its more volatile than the S&P 500 by 80.088%.

  • Which is a Better Dividend Stock VERO or NTRB?

    Venus Concept, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Venus Concept, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios VERO or NTRB?

    Venus Concept, Inc. quarterly revenues are $13.8M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. Venus Concept, Inc.'s net income of -$22.5M is lower than Nutriband, Inc.'s net income of -$3.9M. Notably, Venus Concept, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Venus Concept, Inc. is 0.01x versus 20.66x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    VERO
    Venus Concept, Inc.
    0.01x -- $13.8M -$22.5M
    NTRB
    Nutriband, Inc.
    20.66x -- $346.1K -$3.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
34
Is GOOGL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Sell
46
ZD alert for Mar 4

Ziff Davis, Inc. [ZD] is up 3.64% over the past day.

Buy
54
KORU alert for Mar 4

Direxion Daily MSCI South Korea Bull 3X Shares [KORU] is up 5.43% over the past day.

Sell
40
PSIX alert for Mar 4

Power Solutions International, Inc. [PSIX] is down 1.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock